Genetic diversity in virulence genes of Plasmodium falciparum
恶性疟原虫毒力基因的遗传多样性
基本信息
- 批准号:8004965
- 负责人:
- 金额:$ 13.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-01-15 至 2012-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibody FormationAntigenic VariationAntigensAreaBiologicalBlood capillariesCellsCerebrumCessation of lifeClinicalCodeCommunicable DiseasesComplementDNADNA DamageDNA RepairDataData AnalysesDisease OutbreaksDouble Strand Break RepairEnvironmentErythrocytesEventFamilyGene ConversionGene FamilyGene RearrangementGenerationsGenesGeneticGenetic RecombinationGenetic VariationGenomeGenotypeGoalsHospitalsHumanImmune responseImmune systemIndividualInfectionInternal MedicineInterventionInvestigationMalariaMedical centerMembrane ProteinsMolecularMolecular BiologyNew YorkOrganOrganismParasitesPathogenesisPatientsPharmaceutical PreparationsPhenotypePlasmodium falciparumPlayPresbyterian ChurchPrincipal InvestigatorProcessProgram DevelopmentPropertyProteinsResearchResearch PersonnelResearch ProposalsRoleSamplingSiteSorting - Cell MovementStagingSurface AntigensSurveysSyndromeTestingTimeTrainingTraining ProgramsTransgenic OrganismsTropical MedicineVaccinesVariantVirulenceVirulence FactorsWorkcapillarycareerdesigngenetic analysisgenetic manipulationin vivopathogenprogramspromoterrepairedresponseskillsvaccine development
项目摘要
DESCRIPTION (provided by applicant): The following proposal describes a five-year training program for the development of an academic career in Infectious Diseases. The principal investigator has completed her clinical training in Internal Medicine at Yale New Haven Hospital and Infectious Diseases at New York Presbyterian, Weill Cornell Medical Center. She now aims to develop her research skills studying the molecular biology of the malaria parasite Plasmodium falciparum with the long term goal of establishing an independent research program combining tropical medicine and molecular biology. The principal investigator has developed a customized research proposal integrating molecular biology of DNA repair and the study of tropical medicine.
This proposal will further the understanding of antigenic variation in malaria by integrating the study of the parasite mechanisms for DNA recombination and repair and the genetic analysis of field isolates. Dr. Kirk Deitsch will serve as sponsor and is a leader in the genetic manipulations of P. falciparum. This program is enhanced by the co-sponsorship of Dr. William Holloman, his expertise in DNA recombination and repair enhances both the proposed work and the training of the principal investigator.
Research will focus on the var genes that encode PfEMP1, the primary surface protein implicated in antigenic variation of P. falciparum. This surface protein also determines the cytoadherent properties of an infected red cell, a known virulence factor in P. falciparum infection. Surveys of clinical samples have shown that var genes are extremely diverse genetically. Each parasite isolate contains a complement of -60 var genes that is unique, thus giving each parasite its own distinct repertoire of antigenic molecules. How this extreme diversity is generated has not been extensively explored and is the focus of this research proposal. Transgenic parasite lines will be used to directly study different mechanisms of DNA recombination and repair in P. falciparum. Our transgenic parasite lines have been designed so that we can target DNA damage for repair analysis to var gene coding regions or drug selectable markers driven by var gene promoters. In this way, we will be able to study how DNA damage and subsequent repair may contribute to the generation of diversity in this important gene family. The study of var gene changes in field samples will complement our data generated from the study of transgenic parasites.
Relevance: Appreciation of the mechanisms that generates diversity in this key parasite surface protein is fundamental to understanding the pathogenesis of P. falciparum infections. Further investigation of the host immune response to malaria infection and how the parasite is able to adapt to this response is important in directing intervention efforts, ie vaccines, and findings ways reduce the burden of malaria worldwide.
描述(由申请人提供):以下提案描述了一个为期五年的传染病学术生涯发展培训计划。首席研究员在耶鲁大学纽黑文医院完成了她的内科临床培训,并在纽约长老会医院和威尔康奈尔医学中心完成了感染性疾病培训。她现在的目标是发展自己的研究技能,研究疟疾寄生虫恶性疟原虫的分子生物学,长期目标是建立一个结合热带医学和分子生物学的独立研究项目。首席研究员已经制定了一项定制的研究计划,将DNA修复的分子生物学和热带医学研究结合起来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura Kirkman其他文献
Laura Kirkman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura Kirkman', 18)}}的其他基金
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
跨病灶聚合酶在疟原虫基因组多样化中的作用
- 批准号:
10631907 - 财政年份:2019
- 资助金额:
$ 13.1万 - 项目类别:
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
跨病灶聚合酶在疟原虫基因组多样化中的作用
- 批准号:
10399466 - 财政年份:2019
- 资助金额:
$ 13.1万 - 项目类别:
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
跨病灶聚合酶在疟原虫基因组多样化中的作用
- 批准号:
10840645 - 财政年份:2019
- 资助金额:
$ 13.1万 - 项目类别:
Role of Translesional Polymerases in Genome Diversification of the Malaria Parasite
跨病灶聚合酶在疟原虫基因组多样化中的作用
- 批准号:
10754359 - 财政年份:2019
- 资助金额:
$ 13.1万 - 项目类别:
Genetic diversity in virulence genes of Plasmodium falciparum
恶性疟原虫毒力基因的遗传多样性
- 批准号:
7360009 - 财政年份:2008
- 资助金额:
$ 13.1万 - 项目类别:
Genetic diversity in virulence genes of Plasmodium falciparum
恶性疟原虫毒力基因的遗传多样性
- 批准号:
7740860 - 财政年份:2008
- 资助金额:
$ 13.1万 - 项目类别:
Genetic diversity in virulence genes of Plasmodium falciparum
恶性疟原虫毒力基因的遗传多样性
- 批准号:
8204845 - 财政年份:2008
- 资助金额:
$ 13.1万 - 项目类别:
Genetic diversity in virulence genes of Plasmodium falciparum
恶性疟原虫毒力基因的遗传多样性
- 批准号:
7547778 - 财政年份:2008
- 资助金额:
$ 13.1万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 13.1万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 13.1万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 13.1万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 13.1万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 13.1万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 13.1万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 13.1万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 13.1万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 13.1万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 13.1万 - 项目类别:














{{item.name}}会员




